Intelligence · Clinical Development
Pipeline search results
Programs matching “Astra” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 467 pipeline programs matching "Astra" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
ALLO-HPV
Astra Zeneca AB
Recipients of allogeneic stem cell transplantation
1 trial -
AZD0292
AstraZeneca
Bronchiectasis With Pseudomonas Aeruginosa Colonization
1 trial -
AZD0292, Placebo for AZD0292
AstraZeneca AB
Bronchiectasis with chronic pseudomonas aeruginosa colonization
1 trial -
AZD0486, AZD0486
AstraZeneca AB
Relapsed or Refractory Non-Hodgkin Lymphoma
1 trial -
AZD1163 Placebo, AZD1163
AstraZeneca AB
Rheumatoid arthritis
1 trial -
AZD2265 (FPI-2265)
AstraZeneca
Metastatic Prostate Cancer
1 trial -
AZD2281
AstraZeneca
Ovarian Neoplasms
1 trial -
AZD2962, AZD2962
AstraZeneca AB
Myelodysplastic syndromes, Dysplastic chronic myelomonocytic leukaemia
1 trial -
AZD3632, AZD3632
AstraZeneca AB
Relapsed or refractory acute leukaemia or Myelodysplastic Syndromes with HOX overexpression genotypes
1 trial -
AZD4360
AstraZeneca AB
Gastric Cancer, Gastroesophageal Junction Cancer, Biliary Tract Cancer, Pancreatic Ductal Adenocarcinoma
1 trial -
AZD4512
AstraZeneca AB
B-cell acute lymphoblastic leukemia (B-ALL)
1 trial -
AZD4512
AstraZeneca AB
Non-Hodgkin lymphoma (NHL)
1 trial -
AZD5069
United Therapeutics Europe Ltd
Metastatic Castration Resistant Prostate Cancer
1 trial -
AZD5363 when combined with weekly paclitaxel.
AstraZeneca
Advanced or Metastatic Breast Cancer
1 trial -
AZD6738, Ceralasertib
AstraZeneca AB
Advanced Cancer Whose Tumours Contain Molecular Alterations
1 trial -
AZD6793
AstraZeneca
Chronic Obstructive Pulmonary Disease (COPD)
1 trial -
AZD7789
AstraZeneca AB
Advanced or metastatic gastric and gastro-esophageal junction (GEJ) adenocarcinoma, Advanced or Metastatic Non-small Cell Lung Carcinoma, Advanced or Metastatic Solid Tumors
1 trial -
AZD7798 Placebo, AZD7798
AstraZeneca AB
Crohn's Disease
1 trial -
AZD8931
AstraZeneca
Neoplasms
1 trial -
AZD9668
AstraZeneca
Chronic Obstructive Pulmonary Disease
1 trial -
AZD9750, Saruparib
AstraZeneca AB
Metastatic Prostate Cancer
1 trial -
AZD9793
AstraZeneca AB
Hepatocellular Carcinoma
1 trial -
Abiraterone Acetate
United Therapeutics Europe Ltd
Metastatic Castration Resistant Prostate Cancer
1 trial -
Atuliflapon
AstraZeneca
Asthma
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.